Acute Myeloid Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Suspended
  • Acute Myeloid Leukemia
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center LAO
2021-10-14
Oct 14, 2021
F
Recruiting
  • Acute Biphenotypic Leukemia
  • +9 more
  • Total-Body Irradiation
  • +10 more
  • Tampa, Florida
  • +2 more
2021-10-07
Oct 7, 2021
K
Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • Los Angeles, California
  • +17 more
2021-10-14
Oct 14, 2021
F
Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-10-13
Oct 13, 2021
J
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +24 more
2021-10-14
Oct 14, 2021
E
Terminated
  • Acute Myeloid Leukemia
  • hematopoietic cell transplantation
  • Non-Transplant treatment approach for consolidation
  • Melbourne Victoria, Australia
  • +47 more
2021-10-06
Oct 6, 2021
L
Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
2021-10-07
Oct 7, 2021
G
Recruiting
  • Acute Myeloid Leukemia
  • Stanford, California
  • +2 more
2021-10-11
Oct 11, 2021
V
Recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +11 more
2021-10-12
Oct 12, 2021
U
Active, not recruiting
  • Acute Myeloid Leukemia
  • Azacitidine and Venetoclax
  • Aurora, Colorado
    University of Colorado Denver
2021-10-12
Oct 12, 2021
U
Recruiting
  • Acute Myeloid Leukemia
  • Behavioral: UR-GOAL communication tool
  • Rochester, New York
    University of Rochester Medical Center
2021-10-04
Oct 4, 2021
B
Not yet recruiting
  • Acute Myeloid Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Los Angeles, California
  • +2 more
2021-10-11
Oct 11, 2021
I
Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • HLA-mismatched microtransplantation
  • Marseille, Bouches Du Rhône, France
    Institut Paoli Calmettes
2021-10-11
Oct 11, 2021
A
Completed
  • Acute Myeloid Leukemia
  • AMV564
  • AMV564 in combination with pembrolizumab
  • San Francisco, California
  • +9 more
2021-10-11
Oct 11, 2021
T
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • CAHAG regimen
  • Placebo regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
2021-10-10
Oct 10, 2021
T
Recruiting
  • Adenocarcinoma
  • +75 more
  • Biomarker Testing (L)
  • +2 more
  • Idaho Falls, Idaho
    Teton Cancer Institute
2021-10-04
Oct 4, 2021
M
Recruiting
  • Acute Myeloid Leukemia
  • Hershey, Pennsylvania
    Penn State Cancer Institute
2021-10-04
Oct 4, 2021
D
Recruiting
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-10-04
Oct 4, 2021
A
Terminated
  • Multiple Myeloma
  • +6 more
  • AMG 397
  • +2 more
  • Birmingham, Alabama
  • +20 more
2021-10-08
Oct 8, 2021
L
Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    The First Hospital of Lanzhou University
2021-10-07
Oct 7, 2021